CD101 and cancer: Moreover, KEGG analysis suggested that cytokine–cytokine receptor interaction, ECM–receptor interaction, transcriptional misregulation in cancer, pathways in cancer, chemokine signaling pathway, and primary immunodeficiency were potential pathways in regulating CD101 expression (Figure 5D).